Effects of Newer Veterinary Macrolide Antimicrobials on the CYP3A-Dependent Metabolism in Cattle Liver Microsomes: Potential Metabolic Drug-Drug Interaction with Monensin. [PDF]
Ichinose P +8 more
europepmc +1 more source
Application of Physiologically-Based Pharmacokinetic Modeling to Support Drug Labeling: Prediction of CYP3A4-Mediated Pirtobrutinib-Drug Interactions. [PDF]
Tian DD, Hall SD, Chapman SC, Posada MM.
europepmc +1 more source
Drug-drug interactions with pioglitazone, losartan, and midazolam and anti-tumor efficacy and safety study of TAS-115 in patients with solid tumors. [PDF]
Katsuya Y +3 more
europepmc +1 more source
Impact of aging on the pharmacokinetic profile of everolimus in male mice. [PDF]
Ozturk Civelek D +3 more
europepmc +1 more source
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia. [PDF]
Hoang T +10 more
europepmc +1 more source
The Pivotal Role of GR-CAR Pathway in Fetal Programming of Hepatic Cytochrome P450 3A Alteration in Adulthood. [PDF]
Sun X +9 more
europepmc +1 more source
Effect of Testosterone Therapy on Cytochrome P450 3A and P-Glycoprotein Activities Using Midazolam and Digoxin as Probe Substrates Among Transgender Adults. [PDF]
Hunter M +9 more
europepmc +1 more source
3-Amidinophenylalanine-Derived Inhibitors' Antiviral Effect Against H1N1 Influenza A Virus. [PDF]
Tóth L +9 more
europepmc +1 more source
Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy Participants. [PDF]
Tachibana M +5 more
europepmc +1 more source
Physiologically Based Pharmacokinetic Modeling in Patients With Hepatic Impairment: Are Changes in Bosutinib Exposure Profiles Driven by Altered Absorption or Distribution? [PDF]
Muto C, Jones HM, Yamazaki S.
europepmc +1 more source

